Clinical trial Current Affairs, GK & News
Bharat Biotech Nasal Booster Trials
The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat Biotech, the same company that produces COVAXIN. The boosters are being introduced for the vulnerable population. The booster doses will provide the strength to fight against the third wave that is violently spreading the Omicron. About the ..
Month: Current Affairs - January, 2022
Category: Economy & Banking Current Affairs - 2022 • Science & Technology Current Affairs
Topics: Bharat Biotech • booster dose • Clinical trial • COVAXIN • COVID-19 vaccination • COVID-19 vaccine • Covishield • Drug Controller General of India • Intranasal vaccine
COVAXIN to use Alhydroxiquim-II to boost Immune Response
The first COVID-19 vaccine, COVAXIN is currently in phase II trials in the country. The vaccine is to use Alhydroxiquim-II to boost the immune system. Highlights COVAXIN has sought the approval of Drugs Controller General of India to begin phase III trials. The vaccine was jointly developed by Indian Council of Medical Research and Bharat-Biotech. ..
Month: Current Affairs - October, 2020
Category: India Nation & States Current Affairs
Topics: Clinical trial • COVAXIN • COVID-19 testing • COVID-19 treatment • COVID-19 vaccine • Indian Council of Medical Research
ICMR to launch COVAXIN on August 15
On July 2, 2020, Indian Council of Medical Research announced that it is to launch COVAXIN, India’s first COVID-19 vaccine by August 15. Highlights There are 12 institutes that are conducting the clinical trials of the indigenous vaccine. Currently India has two indigenous manufacturers that are approved to conduct clinical trials for COVID-19 vaccine. They ..
Month: Current Affairs - July, 2020
Category: India Nation & States Current Affairs
Topics: Bharat Biotech • Clinical trial • COVAXIN • COVID-19 vaccine • ICMR • National Institute of Virology (NIV) • Zydus Cadila
Centre issued new Drugs and Clinical Trials Rules, 2019
Health and Family Welfare Ministry have issued the Drugs and Clinical Trials Rules, 2019 with a motive to enhance clinical research in the country. The new rules will alter the regulatory landscape for the approval of new drugs and conduct of clinical trials in the country. These new rules will be applied to all new ..
Topics: Bioequivalence • Clinical research • Clinical trial • Clinical Trials Directive • Health • Investigational New Drug • Medical research • Outline of clinical research
Maharashtra registered Maximum Number of Deaths due to SAEs during Drug Trials
As per the data of the Drug Controller-General of India, India recorded 2061 drug trial-related deaths during the period (January 2008- January 2012). Maharashtra registered maximum number of 268 deaths due to SAEs (Serious Adverse Events) during drug trials while Madhya Pradesh recorded the least number of such deaths.
Month: Current Affairs - August, 2012
Topics: Adverse event • Clinical research • Clinical trial • Health • Madhya Pradesh • Medical research • Pharmaceutical Industry • Serious adverse event
Regulatory Mechanism for Biodiversity sector soon
A regulatory mechanism in Biodiversity sector to be in place following the recommendations Objective: To safeguard public health and protect environment. Quality Control lab in Delhi has been asked to bring wider range of bio-technology products under its ambit to ensure that they are safe and meet the prescribed standards. Private sector requested to increase ..
Month: Current Affairs - February, 2012
Topics: Clinical research • Clinical trial • Design of experiments • Food and Drug Administration • Health • Pharmaceutical Industry